Abstract
The transition to low global warming propellants in pressurized metered dose inhalers (pMDI) [1] introduces a range of challenges for device and formulation design as the new propellants have different physicochemical properties to
those which they replace [2, 3]. One of the many factors influenced by propellant choice is spray plume pattern and geometry [4]. Changes in the targeting angle and spreading rate of the spray can influence mouthpiece and throat deposition as well as aerosol properties [5]. In prior work, it was shown that solution formulations vary in respect of their stability and shot-to-shot repeatability depending on propellant choice, with the cosolvent having a dominant effect [6]. In this work, suspension formulations have been evaluated. The data presented herein show that the presence of suspended particles on mean plume development varies significantly with HFA152a and HFO1234ze(E) propellants when compared to a HFA134a control in matched hardware.
those which they replace [2, 3]. One of the many factors influenced by propellant choice is spray plume pattern and geometry [4]. Changes in the targeting angle and spreading rate of the spray can influence mouthpiece and throat deposition as well as aerosol properties [5]. In prior work, it was shown that solution formulations vary in respect of their stability and shot-to-shot repeatability depending on propellant choice, with the cosolvent having a dominant effect [6]. In this work, suspension formulations have been evaluated. The data presented herein show that the presence of suspended particles on mean plume development varies significantly with HFA152a and HFO1234ze(E) propellants when compared to a HFA134a control in matched hardware.
Original language | English |
---|---|
Title of host publication | Proceedings of Respiratory Drug Delivery 2024 |
Editors | Dalby RN, Peart J, Suman JD, Young PM, Traini D, Watts A. |
Publisher | RDD Online |
Pages | 332-335 |
Number of pages | 4 |
ISBN (Electronic) | 9781739682125 |
Publication status | Published - 2024 |
Event | Respiratory Drug Delivery 2024 - Tuscon, United States of America Duration: 5 May 2024 → 9 May 2024 https://www.rddonline.com/rdd/rdd.php?id=23&sid=1 |
Conference
Conference | Respiratory Drug Delivery 2024 |
---|---|
Abbreviated title | RDD 2023 |
Country/Territory | United States of America |
City | Tuscon |
Period | 5/05/24 → 9/05/24 |
Internet address |